Both hubristic and thick!
The Company has made it clear that a successful reading in March 2024 "will see the company announce a clinically significant and statistically meaningful improvement"
In other words, your interpretation of what 'futility' analysis implies does not apply here. You are implying that the Company management are liars. Its horses for courses but clearly you don't have sufficient grey matter to understand that.
DXB Media thread., page-23
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.020(5.48%) |
Mkt cap ! $208.8M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 38.5¢ | 36.5¢ | $361.8K | 957.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 177441 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 237200 | 8 |
View Market Depth
| Last trade - 13.11pm 02/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |